A ""Hot Topic"" in Drug Discovery

Courtesy of Thermogenic Imaging  FEEL THE HEAT? Infrared TSA images capture the thermogenic response of the brain and IBAT to oral glucose and insulin in diabetic and non-diabetic BB-rats. Cellular thermogenesis, or heat production, reflects an amalgamation of physiological functions, including metabolic activities and blood flow. Telltale differences in thermogenic patterns can result when an organism's physiological status changes for any of a variety of reasons, including disease prog

Written byDeborah Fitzgerald
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Cellular thermogenesis, or heat production, reflects an amalgamation of physiological functions, including metabolic activities and blood flow. Telltale differences in thermogenic patterns can result when an organism's physiological status changes for any of a variety of reasons, including disease progression, exposure to toxins, or therapeutic intervention. Now Billerica, Mass.-based Thermogenic Imaging is using a technology, originally designed to let soldiers see in the dark, to develop a technique called Thermal Signature Analysis (TSA), which enables researchers to visualize and quantify these thermal profiles in cultured cells and live animals.

Comparative TSA studies enable the identification of thermal patterns characteristic of certain phenotypes, disease stages, or responses to drugs or other treatments. Using the technology, scientists can perform noninvasive temperature profiling of live animals as well as cultured cells, with no need for fluorophores, radioactive labels, or reporters.

Thermogenic Imaging is confident that TSA technology will facilitate drug discovery and development, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies